Welcome to LTNR

Laboratory for Translational Nanotechnology Research (LTNR)
University of South Florida

The Laboratory for Translational Nanotechnology Research (LTNR) at the University of South Florida is dedicated to advancing nanomedicine and translational bioengineering to address unmet clinical needs. Our research integrates nanotechnology, biomaterials, molecular biology, and disease-focused models to develop innovative therapeutic and diagnostic platforms with real-world clinical relevance.

Who We Are

The Laboratory for Translational Nanotechnology Research (LTNR) at the University of South Florida is a multidisciplinary research hub focused on harnessing nanotechnology to solve complex biomedical challenges. We specialize in designing and developing nano-engineered systems for targeted drug delivery, diagnostics, and translational therapeutics. By integrating principles from nanoscience, bioengineering, molecular biology, and clinical research, LTNR advances innovative solutions that bridge laboratory discovery with real-world clinical impact.

Our Vision

To be a leading center in translational nanomedicine that drives breakthroughs in disease treatment and diagnosis through rigorous science, creative engineering, and clinical relevance.

Our Mission

• Develop next-generation nanotherapeutics for inflammatory, metabolic, and neurological diseases.

• Engineer biocompatible nano-systems that improve efficacy and safety of therapies.

• Translate fundamental discoveries into clinically viable solutions.

• Foster collaborative research and training across disciplines.

Our Values

• Innovation: We push scientific boundaries and explore novel nano-bio interfaces.

• Excellence: We uphold the highest standards in research quality and integrity.

• Translation: We pursue outcomes that have measurable impact on patient care.

• Collaboration: We work with clinicians, engineers, and scientists to address complex health challenges.

What We Do

Researchers at LTNR conduct cutting-edge studies including:

• Nanoparticle design for controlled and targeted drug delivery.

• Mechanistic evaluation of nano–bio interactions in disease models.

• Development of nanotechnology-based diagnostics and imaging biomarkers.

• Translational validation of nanoformulations for therapeutic use.